FDA Drug Application (021972) for LAMIVUDINE; STAVUDINE; NEVIRAPINE by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number021972
Product Number001
FormTABLET, DISPERSIBLE; ORAL
Dosage30MG; 6MG; 50MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; STAVUDINE; NEVIRAPINE
Active IngredientLAMIVUDINE; STAVUDINE; NEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient NEVIRAPINE17
List of drugs with Active Ingredient STAVUDINE11


Back to FDA Applications sponsored by CIPLA LIMITED